Arbor Pharmaceuticals, LLC Sustainability Profile
Arbor Pharmaceuticals, LLC, headquartered in the United States, is a prominent player in the pharmaceutical industry, specialising in the development and marketing of innovative products for the paediatric and adult markets. Founded in 2006, Arbor has achieved significant milestones, including the expansion of its product portfolio and strategic partnerships that enhance its market presence. The company focuses on niche therapeutic areas, offering unique formulations and delivery systems that cater to specific patient needs. Arbor's commitment to quality and innovation has positioned it as a trusted provider in the healthcare sector, with a growing reputation for excellence in paediatric care. With a robust pipeline and a dedication to improving patient outcomes, Arbor Pharmaceuticals continues to make strides in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Arbor Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Arbor Pharmaceuticals, LLC's score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Arbor Pharmaceuticals, LLC's reported carbon emissions
Arbor Pharmaceuticals, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. It is important to note that Arbor Pharmaceuticals, LLC is a current subsidiary of Azurity Pharmaceuticals, Inc. However, there is no emissions data cascaded from Azurity Pharmaceuticals, Inc. to Arbor Pharmaceuticals, LLC, nor are there any specific climate initiatives reported from this relationship. In the broader context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate commitments. While Arbor Pharmaceuticals may not currently have specific data or targets, the industry trend towards reducing carbon emissions and enhancing environmental responsibility remains significant.
How Carbon Intensive is Arbor Pharmaceuticals, LLC's Industry?
How Carbon Intensive is Arbor Pharmaceuticals, LLC's Location?
Arbor Pharmaceuticals, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Arbor Pharmaceuticals, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
